Table 1.
Baseline characteristics of enrolled participants
| Variable | Total (N = 81) | Treatment Arm | ||
|---|---|---|---|---|
| Metabolism informed care (N = 44) | Guideline based care (N = 37) | |||
| Age (years) | ||||
| Median | 53.5 | 53.2 | 54.4 | |
| Interquartile range | (44.5, 60.6) | 45.8, 60.8 | 43.9, 59.6 | |
| Minimum/maximum | 28.0/79.9 | 28.0/71.9 | 28.6/79.9 | |
| Gender | Female | 36 (44.4%) | 20 (45.5%) | 16 (43.2%) |
| Race | White | 55 (67.9%) | 30 (68.2%) | 25 (67.6%) |
| Black | 23 (28.4%) | 12 (27.3%) | 11 (29.7%) | |
| Heaviness of smoking index | Light | 5 (6.2%) | 3 (6.8%) | 2 (5.4%) |
| Moderate | 35 (43.2%) | 21 (47.7%) | 14 (37.8%) | |
| Heavy | 41 (50.6%) | 20 (45.5%) | 21 (56.8%) | |
| Cigarettes per day over last 7 days | ≥10 | 67 (82.7%) | 35 (79.5%) | 32 (86.5%) |
| Income | <$15000 | 14 (17.3%) | 6 (13.6%) | 8 (21.6%) |
| $15000–$35000 | 21 (25.9%) | 12 (27.3%) | 9 (24.3%) | |
| $35000–$75000 | 24 (29.6%) | 16 (36.4%) | 8 (21.6%) | |
| >$75000 | 10 (12.3%) | 6 (13.6%) | 4 (10.8%) | |
| Don’t know/decline | 12 (14.8%) | 4 (9.1%) | 8 (21.6%) | |
| Education | High school or less | 36 (44.5%) | 21 (47.7%) | 15 (40.5%) |
| Vocational | 8 (9.9%) | 4 (9.1%) | 4 (10.8%) | |
| Some college/college graduate | 37 (45.7%) | 19 (43.2%) | 18 (48.6%) | |
| Audit-C | High (≥3 women, ≥4 men) | 14 (17.3%) | 9 (20.5%) | 5 (13.5%) |
| PHQ-2 | High (≥3) | 10 (12.3%) | 6 (13.6%) | 4 (10.8%) |
| Medication prescribed | Varenicline | 45 (58.4%) | 23 (56.1%) | 22 (61.1%) |
| Bupropion | 7 (9.1%) | 2 (4.9%) | 5 (13.9%) | |
| Nicotine patch | 25 (32.5%) | 16 (39%) | 9 (25%) | |